P Guggenbuhl
Overview
Explore the profile of P Guggenbuhl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robin F, Lescoat A, Jego P, Guggenbuhl P
Rev Med Interne
. 2021 Aug;
42(9):597-599.
PMID: 34353612
No abstract available.
2.
Paccou J, Javier R, Henry-Desailly I, Ternynck C, Nottez A, Legroux-Gerot I, et al.
Osteoporos Int
. 2021 Mar;
32(9):1763-1775.
PMID: 33655400
Introduction: Reports of elevated bone mass (EBM) on routine dual energy X-Ray absorptiometry (DXA) scanning are not infrequent. However, epidemiological studies of EBM are few and definition thresholds are variable....
3.
Guggenbuhl P, Robin F, Cadiou S, Albert J
Morphologie
. 2021 Jan;
105(349):80-84.
PMID: 33451882
Avascular osteonecrosis of the femoral head (ONFH) is one of the causes of hip pain that clinicians need to know about. In many cases, it is a fortuitous discovery when...
4.
Robin F, Cadiou S, Albert J, Bart G, Coiffier G, Guggenbuhl P
Osteoporos Int
. 2020 Oct;
32(2):225-232.
PMID: 33128074
Introduction: Methotrexate (MTX)-related osteopathy is rare, defined by the triad of pain, osteoporosis, and "atypical fractures" when it was first described in the 1970s in children treated with high doses...
5.
Robin F, Berthoud O, Albert J, Cadiou S, Gougeon-Jolivet A, Bendavid C, et al.
Clin Rheumatol
. 2020 Oct;
40(5):1983-1988.
PMID: 33113024
Objective: To evaluate the performance of the Gout-calculator in a cohort of consecutive acute arthritis affecting large and intermediate joints (without an attack on hallux or midfoot joints). Methods: A...
6.
Coiffier G, David C, Gauthier P, Le Bars H, Guggenbuhl P, Jolivet-Gougeon A, et al.
Clin Rheumatol
. 2019 Mar;
38(7):1985-1992.
PMID: 30850963
Objective: To evaluate the diagnostic performance of bacterial identification by broad-range polymerase chain reaction (PCR) of ribosomal DNA (rDNA) 16 s (16S rDNA PCR) for the diagnosis of septic arthritis...
7.
Peltier L, Bendavid C, Cavey T, Island M, Doyard M, Leroyer P, et al.
Osteoporos Int
. 2018 May;
29(8):1905-1915.
PMID: 29721575
Introduction: Systemic iron excess favors the development of osteoporosis, especially during genetic hemochromatosis. The cellular mechanisms involved are still unclear despite numerous data supporting a direct effect of iron on...
8.
Laroche M, Talibart M, Cormier C, Roux C, Guggenbuhl P, Degboe Y
Osteoporos Int
. 2017 Sep;
28(11):3135-3142.
PMID: 28879474
Introduction: In order to define the causes or predisposing factors of pregnancy-related osteoporosis and its clinical, radiological and bone density characteristics, laboratory findings, course and outcome, we carried out a...
9.
Flais J, Coiffier G, Le Noach J, Albert J, Faccin M, Perdriger A, et al.
Arch Osteoporos
. 2017 Mar;
12(1):24.
PMID: 28251468
Purpose: Despite the availability of effective anti-osteoporotic treatments, osteoporosis management is currently insufficient. The main objective of this study was to assess the prevalence of anti-osteoporotic treatments introduced after an...
10.
Lespessailles E, Cortet B, Legrand E, Guggenbuhl P, Roux C
Osteoporos Int
. 2017 Feb;
28(6):1771-1778.
PMID: 28161747
In clinical practice, areal bone mineral density (aBMD) is usually measured using dual-energy X-ray absorptiometry (DXA) to assess bone status in patients with or without osteoporotic fracture. As BMD has...